Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-02-22. In addition, the Company is also into marketing and distribution of bulk ayurvedic medicines. The Company’s portfolio consists of approximately 230 products. The firm offers medicine for acidity, antidandruff, antioxidants, blood purifier & skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, herbal cosmetics, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and weight management. The Company’s products include ASUKA TABLETS, ASUKA TABLETS, ASHWO TABLETS-TONIC FOR BODY AND MIND, RAKTAJ TABLETS / SYRUP-FOR SKIN DISORDERS, NIRMALAYA (PROPRIETORY), DANTA DOSHAHAR MANJAN, HOLETRICA CAPSULE, FEMOHERB SYRUP/TABLETS, MAHABHRUNGRAJ OIL and other.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.